Stakeholder perspectives on decision-analytic modeling frameworks to assess genetic services policy.

about

Issues surrounding the health economic evaluation of genomic technologies.

P2860

Q37541151-17D9803A-810C-472E-8BC0-6124CDC937E3

P2860

Stakeholder perspectives on decision-analytic modeling frameworks to assess genetic services policy.

Item

http://www.wikidata.org/entity/Q44981166

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Stakeholder perspectives on de ...... ssess genetic services policy.

@en

Stakeholder perspectives on de ...... ssess genetic services policy.

@nl

type

Item

label

Stakeholder perspectives on de ...... ssess genetic services policy.

@en

Stakeholder perspectives on de ...... ssess genetic services policy.

@nl

prefLabel

Stakeholder perspectives on de ...... ssess genetic services policy.

@en

Stakeholder perspectives on de ...... ssess genetic services policy.

@nl

P1476

Stakeholder perspectives on de ...... ssess genetic services policy.

@en

P2093

David L Veenstra

http://www.w3.org/2001/XMLSchema#string

Debra Lochner Doyle

http://www.w3.org/2001/XMLSchema#string

Gregory F Guzauskas

http://www.w3.org/2001/XMLSchema#string

Jacquie Stock

http://www.w3.org/2001/XMLSchema#string

Louis P Garrison

http://www.w3.org/2001/XMLSchema#string

Sylvia Au

http://www.w3.org/2001/XMLSchema#string

P2860

Three approaches to qualitative content analysis

Stakeholder perspectives on a risk-benefit framework for genetic testing.

A formal risk-benefit framework for genomic tests: facilitating the appropriate translation of genomics into clinical practice.

A policy model to evaluate the benefits, risks and costs of warfarin pharmacogenomic testing.

Modeling for health care and other policy decisions: uses, roles, and validity.

Evidence-based classification of recommendations on use of genomic tests in clinical practice: dealing with insufficient evidence.

Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.

A review of public policy issues in promoting the development and commercialization of pharmacogenomic applications: challenges and implications

Deploying whole genome sequencing in clinical practice and public health: meeting the challenge one bin at a time

P2888

gim.2012.92

P304

84-87

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/GIM.2012.92

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230573378

http://www.w3.org/2001/XMLSchema#string

P698

22836698

http://www.w3.org/2001/XMLSchema#string

Stakeholder perspectives on decision-analytic modeling frameworks to assess genetic services policy.

about

P2860

P2860

Stakeholder perspectives on decision-analytic modeling frameworks to assess genetic services policy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P5875

P698